In:
International Journal of Dermatology and Venereology, Ovid Technologies (Wolters Kluwer Health), Vol. 3, No. 2 ( 2020-03-27), p. 76-85
Abstract:
Biologic drugs have been increasingly used in the treatment of psoriasis and are especially favorable for severe, recalcitrant, and special-type cases. Therefore, appropriate, effective, and safe use of biologic drugs has drawn attention from dermatologists. For this purpose, Chinese experts majoring in psoriasis analyzed domestic and international research data, summarized current clinical experiences, investigated features of Chinese patients with psoriasis, and finally formulated the present consensus, which provides detailed guidances to clinicians in terms of the principles and methods of the application of biologics, the efficacy and safety profile, patient screening and monitoring, main adverse events and corresponding solutions, and precautions for special patient populations.
Type of Medium:
Online Resource
ISSN:
2096-5540
,
2641-8746
DOI:
10.1097/JD9.0000000000000079
Language:
English
Publisher:
Ovid Technologies (Wolters Kluwer Health)
Publication Date:
2020
detail.hit.zdb_id:
3045655-1
Bookmarklink